Related Experiment Video
Updated: Aug 11, 2026

Chromosomics: Detection of Numerical and Structural Alterations in All 24 Human Chromosomes Simultaneously Using a Novel OctoChrome FISH Assay
Published on: February 6, 2012
Dinitrochlorobenzene is genotoxic by sister chromatid exchange in human skin fibroblasts
1Department of Pharmacology, Hospital for Sick Children, Toronto, Ont., Canada. deleve@hsc.usc.edu
Abstract:
Dinitrochlorobenzene (DNCB) is clinically efficacious in the therapy of alopecia areata, but its use was limited when it was found to be mutagenic in the Ames test. However, there has been renewed interest in the immunomodulatory benefits of topically applied dinitrochlorobenzene in patients with human immunodeficiency virus and systemic lupus erythematosus. The current study examines the genotoxicity of dinitrochlorobenzene in human skin fibroblasts using sister chromatid exchange. Dinitrochlorobenzene caused a significant increase in sister chromatid exchange at concentrations ranging from 2.5 to 10 microM. Thus, dinitrochlorobenzene is genotoxic in human skin fibroblasts at concentrations well below those used clinically. The potential for long-term toxicity from dinitrochlorobenzene will have to be weighed against the severity and prognosis of the diseases for which it is used.
Insights
Dinitrochlorobenzene (DNCB) shows genotoxicity in human skin cells, increasing sister chromatid exchange at low concentrations. This finding necessitates careful consideration of its clinical use versus potential long-term toxicity risks.
Area of Science:
- Toxicology
- Dermatology
- Genetics
Background:
- Dinitrochlorobenzene (DNCB) is an effective treatment for alopecia areata.
- Previous mutagenicity findings in the Ames test limited DNCB's clinical application.
- Renewed interest exists for DNCB's immunomodulatory effects in HIV and lupus erythematosus patients.
Purpose of the Study:
- To investigate the genotoxicity of DNCB in human skin fibroblasts.
- To evaluate DNCB's potential to induce sister chromatid exchange (SCE).
Main Methods:
- Human skin fibroblasts were exposed to varying concentrations of DNCB.
- Sister chromatid exchange assay was performed to assess genotoxicity.
Main Results:
- DNCB significantly increased sister chromatid exchange in human skin fibroblasts.
- Genotoxicity was observed at concentrations from 2.5 to 10 microM.
- These effective concentrations are below those typically used in clinical settings.
Conclusions:
- Dinitrochlorobenzene is genotoxic to human skin fibroblasts at clinically relevant concentrations.
- The potential risks of DNCB genotoxicity must be balanced against its therapeutic benefits for severe conditions.
More Related Videos
Related Concept Videos
Nucleotide Excision Repair
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mutagenicity and Carcinogenicity
Spontaneous and Induced Mutations
Other Unique Bacteria

